NDC 70710-1165-06 - Oseltamivir Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1165
- Requested NDC
- 70710-1165-06
- Package NDCs from labels
- 70710-1165-6, 70710-1165-06
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oseltamivir Phosphate - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-08-10 | HUMAN PRESCRIPTION DRUG LABEL |
| OSELTAMIVIR ACID - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2023-03-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Oseltamivir Phosphate - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Oseltamivir Phosphate - A-S Medication Solutions | A-S Medication Solutions | 2020-01-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1165-6 | OSELTAMIVIR PHOSPHATE | 1 in 1 CARTON | FOR SUSPENSION | 1 | 8 | |
| 70710-1165-6 | OSELTAMIVIR PHOSPHATE | 60 mL in 1 BOTTLE | FOR SUSPENSION | 60 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1165 | OSELTAMIVIR PHOSPHATE FOR SUSPENSION [ZYDUS PHARMACEUTICALS USA INC.] | 8 | Current NDC, Legacy NDC, 2 package rows | 20230317_432d9e7b-9cb2-4b7d-9fb2-015449096757.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1165-6 | ML - Milliliter | 70710-1165 | 0e3a3266-469e-433b-b994-33c6227a273f | 1 | 2017-12-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Zydus Pharmaceuticals USA Inc. | 432d9e7b-9cb2-4b7d-9fb2-015449096757 | 2023-03-13 | Warnings, Adverse reactions | ANDA209113 70710-1165-6 70710-1165 70710116506 1115698 73c48039-409b-4769-ab13-fc929efe0e28 432d9e7b-9cb2-4b7d-9fb2-015449096757 4A3O49NGEZ |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Mineral Sunscreen SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 3a637542-0f79-47ae-815d-84d0036c737a | 2023-02-13 | Warnings | 15FIX9V2JP |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | 73d7fa5a-8304-44b7-9456-58926a265d81 | 2023-02-06 | Warnings, Adverse reactions | 1115698 4A3O49NGEZ |
| OSELTAMIVIR | OSELTAMIVIR | Alembic Pharmaceuticals Limited | 0a7181a6-e9eb-4047-a26f-4268f174db16 | 2023-01-30 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Sodium Phenylacetate and Sodium Benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS | ab40b62b-9f8d-4394-92d5-09d9f1941eaa | 2023-01-16 | Warnings, Adverse reactions | OJ245FE5EU |
| Josie Maran Argan Daily Moisturizer SPF47 | ZINC OXIDE, TITANIUM DIOXIDE | Autumn Harp, Inc. | 027821e6-db7d-4c03-956a-00313488ebc7 | 2023-01-14 | Boxed warning, Warnings | 15FIX9V2JP |
| ChemDetox | BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), PHYTOLACCA DECANDRA, THYROIDINUM (SUIS), IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM | Dr. Donna Restivo DC | 2a17f80d-12c0-43a0-980b-9da648e9b76a | 2023-01-10 | Warnings | 506T60A25R |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Zydus Pharmaceuticals USA Inc. | 0e666061-1bfd-48cd-896b-ded8298a1847 | 2022-12-27 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | cd0236c6-317c-47b1-9185-3253dba4bb37 | 2022-11-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | Proficient Rx LP | 09e119eb-a8fa-4635-96a7-1b134593cdca | 2022-11-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye wash | PURIFIED WATER | McKesson | bd089fde-24ba-4de5-e053-2995a90a39bb | 2022-10-18 | Warnings | 059QF0KO0R |
| Bach Original Flower Remedies Rock Water | WATER | Nelson Bach USA Limited | ea242559-1618-3354-e053-2a95a90a1a95 | 2022-10-03 | Warnings | 059QF0KO0R |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Amneal Pharmaceuticals NY LLC | c1a280d0-4ce9-494a-9924-eb5621ce3757 | 2022-09-30 | Warnings, Adverse reactions | 1115698 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Asclemed USA, Inc. | 00be0870-2ebb-46e3-9e98-a8f068ec664a | 2022-09-22 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Sterile Water | WATER | Medical Purchasing Solutions, LLC | e90b47e3-9636-b9ee-e053-2a95a90ad48c | 2022-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 1f754ad7-9df0-4121-8051-0a09491be3c7 | 2022-09-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | c754c2f7-7109-4498-aeee-c8ee088dfa98 | 2022-09-01 | Warnings, Adverse reactions | 1115698 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR | Amneal Pharmaceuticals NY LLC | d306e22c-0cb8-46cb-9a40-8194a2bc9e85 | 2022-08-30 | Warnings, Adverse reactions | 4A3O49NGEZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.